Net Medical Xpress Announces Reverse Stock Split
20 June 2016 - Net Medical Xpress Solutions, Inc. (OTCQB SYMBOL: NMXS), a provider of a wide range of telemedicine services, announced today that effective at 5:00 p.m., Eastern Time, on June 20, 2016 (the “Effective Time”), the Company will effect a one-for-nine reverse stock split of its outstanding common stock. The reverse stock split, which was unanimously approved by the Company’s Board of Directors, was approved by its stockholders at the Annual Meeting of Stockholders held on March 31, 2016. The Company’s common stock will open for trading on the OTC QB market on June 21, 2016 on a post-split basis.
As a result of the reverse stock split, every nine shares of the Company's common stock issued and outstanding at the Effective Time will be consolidated into one issued and outstanding share. No fractional shares of common stock will be issued as a result of the reverse stock split. Stockholders with at least one who share will have their fractional shares rounded up. There is no need to submit certificates for exchange; however, to receive a new certificate the pre-split certificate must be submitted to the Company’s transfer agent. Stockholders with only a fractional share will be paid for their pre-split shares at the closing price on June 20, 2016, upon delivery of the pre-split stock certificate to the Company’s transfer agent. Proportional adjustments will be made to Net Medical’s outstanding warrants and stock options. The Company’s authorized shares and the par value per share of $0.001 will remain unchanged.
Trading of the Company’s common stock on the OTC QB market will continue, on a split-adjusted basis, with the opening of the markets on Tuesday, June 21, 2016, under the existing trading symbol “NMXS” and under a new CUSIP number 64111U204. The reverse stock split reduces the number of shares of the Company’s common stock outstanding from 174,622,470 million pre-reverse split shares to 19,402,796 million post-reverse split shares.
Richard Govatski, the Company’s chief executive officer, stated: “This move by the Company is expected to improve earnings per share which, when coupled with our continually improving operating performance, is expected to position the Company to achieve a listing on the NASDAQ Small Cap Market.”
Information for Stockholders
The Company has retained its transfer agent, Interwest Transfer, to act as its exchange agent for the reverse stock split. Interwest will provide stockholders of record as of the Effective Time a letter of transmittal providing instructions for the exchange of their stock certificates. Stockholders owning shares via a broker or other nominee will have their positions automatically adjusted to reflect the reverse stock split, subject to such brokers' particular processes, and will not be required to take any action in connection with the reverse stock split.
Net Medical Partners with eazyScripts to Provide Electronic Prescriptions through Telemedicine Doctors
16 June 2016 - Net Medical Xpress Solutions, Inc. (OTCQB SYMBOL: NMXS), a provider of a wide range of telemedicine services, announced today that it has partnered with eazyScripts, an electronic prescription platform to provide electronic prescribing services to patients remotely through telemedicine physicians who serve populations across the nation.
Dick Govatski, CEO of Net Medical Xpress, said, “New York State has blazed the path in mandating electronic prescriptions. Net Medical Xpress is quickly following suit in an effort to eliminate paperwork, improve the speed of prescription transmission from doctors to pharmacies, enhance the doctor-patient interaction and quality of care at the point of treatment and improve prescription fulfillment rates due to pricing transparency.”
Todd Occomy, CEO of eazyScripts, said, “eazyScripts is pleased to have won the opportunity to partner with Net Medical Xpress because the company has emerged as a full service telemedicine company with the capability to recruit, credential and support physicians across a variety of medical disciplines. eazyScripts looks forward to working with Net Medical Xpress, as it onboards clinicians, including physicians and psychiatrists, that specialize in transgender care.”
The eazyScripts platform provides telemedicine physicians with the ability to submit electronic prescriptions, check prescription fill data, secure electronic prior authorization at the touch of a button, reducing inefficiencies and errors. eazyScripts offers medication adherence options which has increased patient satisfaction.
Net Medical Selected to Manage Physicians Group for My On Call Doc’s Gender Care Program
16 May 2016 - Net Medical Xpress Solutions, Inc. (OTCQB SYMBOL: NMXS), said today it is adding to its physician group providers to cover the newly created Gender Care program with My OnCallDoc. The company’s Huntsville staffing division is gearing up to provide specially trained physicians for transgender consults.
As part of the agreement with MyOnCallDoc, Net Medical will on-board an additional 1,200 clinicians including physicians, psychiatrists, and psychologists, that specialize in transgender care.
MyOnCallDoc, a leading international telemedicine company that connects patients with providers, is launching a 60-day pilot program serving the transgender community. MyOnCallDoc CEO Craig Zurman said, “The widely dispersed transgender community has a need for physicians that are specifically trained to manage transgender care. Our international platform is ideal for easily and effectively connecting patients with providers worldwide.”
The formal partnership agreement with the World Professional Association of Transgender Health (wpath.org) provides health care to the transgender community members. The program is known as GenderCare.
World Professional Association for Transgender Health President Dr. Jamison Green commented, “We are excited to offer telemedicine to our members and partner networks, making access to care easier than ever before. Our specialized clinicians will now be able to deliver care to transgender patients in the privacy of their homes. This is a big deal for trans* people who do not have ready access to quality care.” The company plans a full U.S. domestic rollout on July 14, and an international launch on September 1, 2016.
More information can be found at gendercare.us